Pritchard, C.; Kutikova, L.; Pitman, R.; Lai, K.Z.H.; Beyhaghi, H.; Gibbons, I.; Erbe, A.; Živković-Gojović, M.; Cosgrove, C.; Sculpher, M.;
et al. Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model. Vaccines 2025, 13, 187.
https://doi.org/10.3390/vaccines13020187
AMA Style
Pritchard C, Kutikova L, Pitman R, Lai KZH, Beyhaghi H, Gibbons I, Erbe A, Živković-Gojović M, Cosgrove C, Sculpher M,
et al. Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model. Vaccines. 2025; 13(2):187.
https://doi.org/10.3390/vaccines13020187
Chicago/Turabian Style
Pritchard, Clive, Lucie Kutikova, Richard Pitman, Kira Zhi Hua Lai, Hadi Beyhaghi, IIana Gibbons, Amanda Erbe, Marija Živković-Gojović, Catherine Cosgrove, Mark Sculpher,
and et al. 2025. "Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model" Vaccines 13, no. 2: 187.
https://doi.org/10.3390/vaccines13020187
APA Style
Pritchard, C., Kutikova, L., Pitman, R., Lai, K. Z. H., Beyhaghi, H., Gibbons, I., Erbe, A., Živković-Gojović, M., Cosgrove, C., Sculpher, M., & Salisbury, D.
(2025). Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model. Vaccines, 13(2), 187.
https://doi.org/10.3390/vaccines13020187
